Nerandomilast, a Preferential Phosphodiesterase 4B Inhibitor, Dampens T-Cell Activation and Effector Function (ACR Convergence 2026) - Sep 8, 2026 - Abstract #972; Pres time: Nov 9, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Immunology • Inflammation
|